Ocular herpes simplex virus (HSV) infection is a global public health concern and a leading cause of infectious blindness. HSV type 1 predominantly affects the eye, establishing latency in the ...

Please provide your email address to receive an email when new articles are posted on . Antiviral treatment remains a cornerstone in preventing recurrence and reducing post-herpetic pain in herpes ...

Low-dose suppressive valacyclovir treatment of herpes zoster ophthalmicus (HZO) did not show significant benefits at 12 months but showed treatment superiority at 18 months and a reduction in the ...

Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus FDA-approved, standard of care treatments Acyclovir and Abreva in a preclinical animal model. In the ...

Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that will make you thankful for the existence of herpes and other viruses.

Approximately two-thirds of the world's population under the age of 50 years have oral or genital herpes simplex type 1 (HSV-1) infection, while one in eight have herpes simplex type 2 (HSV-2) ...

Herpes simplex virus is a common infection that typically appears in and around the mouth (oral herpes) or the genitals (genital herpes). Ulcers may cause pain but usually resolve within a few days or ...